Resultados de procura - David J. Pinato

Limitar resultados
  1. 1
    Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?

    Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association? por Nadiya Hussain, Muntaha Naeem, David J. Pinato

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

    A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) por David J. Pinato, Bernard V. North, Rohini Sharma

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma

    The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma por Chandan Sanghera, Jhia Jiat Teh, David J. Pinato

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy

    NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy por Matthias Pinter, David J. Pinato, Pierluigi Ramadori, Mathias Heikenwälder

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Hepatocellular carcinoma

    Hepatocellular carcinoma por David J. Pinato, Alessia Dalla Pria, Rohini Sharma, Mark Bower

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma

    Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma por Philip J. Johnson, David J. Pinato, Anton Kalyuzhnyy, Hidenori Toyoda

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    PD-L1

    PD-L1 por Anthousa Kythreotou, Abdul Siddique, Francesco Mauri, Mark Bower, David J. Pinato

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

    Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma por Michael Flynn, Anwar A. Sayed, Rohini Sharma, Abdul Siddique, David J. Pinato

    Publicado 2018
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

    Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma por David J. Pinato, Francesco Mauri, Rathi Ramakrishnan, Lutful Wahab, Tyler Lloyd, Rohini Sharma

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy

    Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy por Leila Motedayеn Aval, James E. Pease, Rohini Sharma, David J. Pinato

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma

    ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma por Coşkun Özer Demirtas, Antonio D’Alessio, Lorenza Rimassa, Rohini Sharma, David J. Pinato

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?

    Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? por Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David J. Pinato, Lorenza Rimassa

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer

    Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer por David J. Pinato, Robert J. Shiner, Michael J. Seckl, Justin Stebbing, Rohini Sharma, Francesco Mauri

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients

    Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients por Alessia Dalla Pria, David J. Pinato, Jennifer Roe, Kikkeri N. Naresh, Mark Nelson, Mark Bower

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future

    Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future por Amit G. Singal, Mark Yarchoan, Adam C. Yopp, Gonzalo Sapisochín, David J. Pinato, Anjana Pillai

    Publicado 2024
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior

    Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior por David J. Pinato, James R. Black, Sebastian Trousil, Roberto Dina, Pritesh Trivedi, Francesco Mauri, Rohini Sharma

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis

    Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis por Dariusz Lachowski, Ernesto Cortés, Alistair Rice, David J. Pinato, Krista Rombouts, Armando E. del Río Hernández

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review

    Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review por Peter R. Galle, Richard S. Finn, Catherine Mitchell, Kerigo Ndirangu, Zahra Ramji, Gabrielle Redhead, David J. Pinato

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  19. 19
    Immunotherapy in Hepatocellular Carcinoma

    Immunotherapy in Hepatocellular Carcinoma por Claudia Angela Maria Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)

    A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI) por David J. Pinato, Justin Stebbing, Mitsuru Ishizuka, Shahid A. Khan, Harpreet Wasan, Bernard V. North, Keiichi Kubota, Rohini Sharma

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: